An imaging agent for amyloid

Med Lett Drugs Ther. 2012 Jul 9;54(1394):54-5.
No abstract available

MeSH terms

  • Adult
  • Alzheimer Disease / diagnostic imaging
  • Amyloid beta-Peptides / metabolism
  • Aniline Compounds*
  • Cognition Disorders / diagnostic imaging
  • Drug Approval
  • Ethylene Glycols*
  • Humans
  • Positron-Emission Tomography / methods*
  • Radiopharmaceuticals*
  • Sensitivity and Specificity
  • United States
  • United States Food and Drug Administration

Substances

  • Amyloid beta-Peptides
  • Aniline Compounds
  • Ethylene Glycols
  • Radiopharmaceuticals
  • florbetapir